Celgene Maintains Earnings Promises, But Jolts The Balance Sheet And Returns

Celgene Maintains Earnings Promises, But Jolts The Balance Sheet And Returns


However, the balance sheet was levered up, and Return on Capital Invested took a hit in order to maintain aggressive growth aspirations. Recently, bio-pharma heavyweight Celgene Corp. reported another set of solid 4Q and full-year results.



from Biotech News